Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23281 AL 23295

Validation study of the Persian version of behavioral pathology in Alzheimer's Disease Rating scale (BEHAVE-AD) and the empirical BHAVE-AD (E-BEHAVE-AD)

Noroozian M, Vahabi Z, Hooshyari Z, Etesam F, Tarighatnia H.

Appl Neuropsychol Adult. 2025 Mar-Apr;32(2):431-441. doi: 10.1080/23279095.2023.2175680. Epub 2023 Feb 11.

Health App Review Tool (HART): Content validation through expert panel review

Moon S, Best K, Choi YK, Faieta J.

Assist Technol. 2025 Feb 14;37(sup1):S3-S8. doi: 10.1080/10400435.2024.2337857. Epub 2024 Apr 17.

Reproducibility and validity of adapted clinical tests for the assessment of muscle strength in community-dwelling older adults living with Alzheimer's disease

de Oliveira MPB, Calixtre LB, de Castro Cezar NO, Lima-Truax C, Truax BD, de Medeiros Takahashi AC, de Oliveira Sato T, Pelicioni PHS, da Silva Serrão PRM, de Andrade LP.

BMC Geriatr. 2025 Aug 18;25(1):636. doi: 10.1186/s12877-025-06269-x.

Preliminary Validation of the FCD-Q8 Tool in Functional Cognitive Disorder and Early Alzheimer's Disease: A Biomarker-Verified Case-Control Study

García-Roldán E, Almodóvar-Sierra Á, Luque-Tirado A, Marín Cabañas AM, Bernal Sánchez-Arjona M, Franco-Macías E.

Eur J Neurol. 2025 Nov;32(11):e70383. doi: 10.1111/ene.70383.

Clinical validation of new alzheimer disease diagnosis tools based on plasma p-Tau217

Martí-Navia A, Álvarez-Sánchez L, Ferré-González L, López A, Peña-Bautista C, Balaguer Á, Pedrosa N, Vico H, Baquero M, Cháfer-Pericás C.

Sci Rep. 2025 Dec 7;16(1):1472. doi: 10.1038/s41598-025-31613-x.

Hyperspectral retinal imaging to detect Alzheimer's disease in a memory clinic setting

Dallora AL, Alexander J, Palesetti PP, Guenot D, Selvander M, Berglund JS, Behrens A.

Alzheimers Res Ther. 2025 Oct 28;17(1):232. doi: 10.1186/s13195-025-01887-4.

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study

Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D.

J Alzheimers Dis. 2025 Mar;104(1):52-60. doi: 10.1177/13872877251313819. Epub 2025 Feb 5.

Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity

Hou J, Hess JL, Zhang C, van Rooij JGJ, Hearn GC, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Seshadri S; Alzheimer's Disease Neuroimaging Initiative; Holmans P, Tsuang MT, Kremen WS, Gaiteri C, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2025 Jun;198(4):e33019. doi: 10.1002/ajmg.b.33019. Epub 2024 Dec 16.

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023

Anschuetz A, Schwab K, Harrington CR, Wischik CM, Riedel G.

J Alzheimers Dis. 2025 Sep;107(2):452-476. doi: 10.1177/13872877251362212. Epub 2025 Sep 1.

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis

Ye H, Zhuang C, Jin Z, Hu Y, He J, Yu Q, Hu H, Zheng Y.

J Alzheimers Dis. 2025 Dec;108(3):1073-1087. doi: 10.1177/13872877251385244. Epub 2025 Oct 17.

Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements

Zhang N, Nao J, Dong X.

Curr Neuropharmacol. 2025;23(6):728-754. doi: 10.2174/1570159X23666241211095018.

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

Puerta R, de Rojas I, García-González P, Olivé C, Sotolongo-Grau O, García-Sánchez A, García-Gutiérrez F, Montrreal L, Tartari JP, Sanabria Á, Pytel V, Lage C, Quintela I, Aguilera N, Rodriguez-Rodriguez E, Alarcón-Martín E, Orellana A, Pastor P, Pérez-Tur J, Piñol-Ripoll G, López de Munain A, García-Alberca JM, Royo JL, Bullido MJ, Álvarez V, Real LM, Corbatón Anchuelo A, Gómez-Garre D, Martínez Larrad MT, Franco-Macías E, Mir P, Medina M, Sánchez-Valle R, Dols-Icardo O, Sáez ME, Carracedo Á, Tárraga L, Alegret M, Valero S, Marquié M, Boada M, Sánchez Juan P, Cavazos JE, Cabrera-Socorro A, Cano A, Ruiz A; Alzheimer’s Disease Neuroimaging Initiative.

Funct Integr Genomics. 2025 Mar 25;25(1):73. doi: 10.1007/s10142-025-01581-6.

Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition

Kim JP, Jung SH, Jang B, Cho M, Song M, Kim J, Kim B, Lee H, Shin D, Lee EH, Jang H, Kim BH, Ham H, Kim D, Raj T, Cruchaga C, Kim HJ, Na DL, Seo SW, Won HH.

Nat Commun. 2025 Apr 2;16(1):3150. doi: 10.1038/s41467-025-57751-4.

The whole-brain structural and functional connectome in Alzheimer's disease spectrum: A multimodal Bayesian meta-analysis of graph theoretical characteristics

Liu W, Zuo C, Chen L, Lan H, Luo C, Li X, Kemp GJ, Lui S, Suo X, Gong Q.

Neurosci Biobehav Rev. 2025 Jul;174:106174. doi: 10.1016/j.neubiorev.2025.106174. Epub 2025 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias